EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
Status:
Not yet recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
The primary hypothesis being tested in this trial is that ischemic stroke patients in
posterior circulation at 4.5 - 24 hours post onset of stroke will have improved clinical
outcomes when given intravenous tissue plasminogen activator (tPA) compared to standard care.
Phase:
Phase 3
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University